Prophylactic use of vacuum-assisted closure system for cannula sites: A case of extracorporeal biventricular assist devices for 295 days

Int J Artif Organs. 2022 Feb;45(2):227-230. doi: 10.1177/0391398821991156. Epub 2021 Feb 2.

Abstract

We report wound management using a vacuum-assisted closure (VAC) system for the cannula sites of extracorporeal biventricular assist devices (BiVADs) for 295 days in a 23-year old Chinese female patient with fulminant giant cell myocarditis, who finally underwent heart transplantation. When the cannula sites appeared necrotic 3 months after BiVADs placement, she received negative pressure wound therapy prophylactically for four cannula sites, using a VAC system for 3 months, followed by no infections. Such prophylactic VAC therapy, using the skin barrier paste usually used for the ostomy pouching system to create a flatter surface and airtightness, may be useful to avoid cannula site infections, which is still a fatal complication causing sepsis, especially in patients with extracorporeal BiVADs.

Keywords: Extracorporeal biventricular assist devices; cannula site; negative pressure wound therapy; vacuum-assisted closure system.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cannula
  • Female
  • Heart-Assist Devices* / adverse effects
  • Humans
  • Negative-Pressure Wound Therapy*
  • Sepsis* / etiology
  • Sepsis* / prevention & control
  • Surgical Wound Infection
  • Young Adult